000 00721nam a2200109Ia 4500
008 230617s9999 xx 000 0 und d
100 _aHirofumi Ochi et al
245 0 _a72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org//sites/default/files/2023-06/72-week_safety_and_tolerability_of_dimethyl_fumarate_in_japanese_patients_with_relapsing-remitting_multiple_sclerosis_analysis_of_the_randomised_double_blind_placebo-controlled.pdf
942 _cEBK
999 _c15199
_d15199